Abstract
Deregulation of PI3K/Akt/mTOR pathway has been recently identified to play a crucial role in the progress of human gastric cancer. In this study, we show that mefloquine, a FDA-approved anti-malarial drug, effectively targets human gastric cancer cells. Mefloquine potently inhibits proliferation and induces apoptosis of a panel of human gastric cancer cell lines, with EC50 ∼ 0.5-0.7 μM. In two independent gastric cancer xenograft mouse models, mefloquine significantly inhibits growth of both tumors. The combination of mefloquine with paclitaxel enhances the activity of either drug alone in in vitro and in vivo. In addition, mefloquine potently decreased phosphorylation of PI3K, Akt, mTOR and rS6. Overexpression of constitutively active Akt significantly restored mefloquine-mediated inhibition of mTOR phosphorylation and growth, and induction of apoptosis, suggesting that mefloquine acts on gastric cancer cells via suppressing PI3K/Akt/mTOR pathway. We further show that mefloquine-mediated inhibition of Akt/mTOR singaling is phosphatase-dependent as pretreatment with calyculin A does-dependently reversed mefloquine-mediated inhibition of Akt/mTOR phosphorylation. Since mefloquine is already available for clinic use, these result...Continue Reading
References
Sep 6, 1996·The Journal of Biological Chemistry·A D KohnR A Roth
Nov 22, 1996·Biochemical Pharmacology·C D RiffkinL Tilley
Jan 28, 2004·Acta Tropica·Sasithon PukrittayakameeNicholas J White
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Oct 3, 2009·PLoS Genetics·Chia Huey OoiPatrick Tan
Jan 15, 2010·Nature Medicine·Matthew R JanesDavid A Fruman
May 24, 2011·Cancer Research·Marco MazzolettiMassimo Broggini
Feb 9, 2012·Gut·Niantao DengPatrick Tan
Mar 17, 2012·Clinical Neurology and Neurosurgery·Remington Lee Nevin
Apr 3, 2012·Neuroscience Letters·Ji Hyun ShinDong-Hyung Cho
Aug 7, 2012·Cancer Letters·Natasha SharmaStan G Louie
Dec 4, 2012·The Journal of Clinical Investigation·Mahadeo A SukhaiAaron D Schimmer
Jun 14, 2013·Oncology Letters·Kun-Huang YanLiang-Ming Lee
Aug 22, 2013·Chemical Biology & Drug Design·Felipe A R RodriguesMarcus V N de Souza
Nov 29, 2013·Biochemical and Biophysical Research Communications·Ju-Hwa KimSungpil Yoon
May 23, 2014·Virchows Archiv : an International Journal of Pathology·Oscar TapiaJuan Carlos Roa
Sep 25, 2015·Clinical and Experimental Pharmacology & Physiology·Jiezhong ChenWenyi Gu
Oct 6, 2015·Oncogene·E SalasJ Debnath
Citations
Nov 11, 2016·Canadian Journal of Physiology and Pharmacology·Hui LiXianrong Wang
Aug 28, 2019·Journal of Cellular Biochemistry·Jie WangXiaxia Wang
Oct 13, 2018·Cancers·Henry D McCannAndrew R Tee
Aug 28, 2020·Frontiers in Oncology·Yifei XieKangdong Liu
Jan 20, 2019·Current Topics in Medicinal Chemistry·Kamakshi DanduCh Mohan Rao
Jul 22, 2017·Oncology Reports·Tao ChenXianzhou Tong
Oct 9, 2020·Journal of Experimental & Clinical Cancer Research : CR·Faiqa MudassarEric Hau
Dec 29, 2020·Frontiers of Medicine·Weibao SongJiandong Jiang
Oct 15, 2020·Gene·Weiwei ZhengChengdang Wang
Jul 3, 2021·Cancers·Christina PfabNahed El-Najjar
Feb 2, 2021·ACS Omega·Abhishek KumarAkash Ranjan